Provided by Tiger Trade Technology Pte. Ltd.

Sight Sciences, Inc.

5.87
+0.18003.16%
Post-market: 5.870.00000.00%17:43 EST
Volume:152.59K
Turnover:890.20K
Market Cap:310.36M
PE:-6.57
High:5.99
Open:5.83
Low:5.60
Close:5.69
52wk High:9.24
52wk Low:2.03
Shares:52.87M
Float Shares:28.82M
Volume Ratio:0.60
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8940
EPS(LYR):-1.0274
ROE:-57.91%
ROA:-20.47%
PB:4.83
PE(LYR):-5.71

Loading ...

Sight Sciences Extends Menlo Park Headquarters Lease Agreement

TIPRANKS
·
Feb 04

Sight Sciences Inc : William Blair Resumes Coverage With Outperform Rating

THOMSON REUTERS
·
Jan 30

Sight Sciences resumed with an Outperform at William Blair

TIPRANKS
·
Jan 30

Top Brass at Sight Sciences Quietly Cashes In With Major Stock Disposals

TIPRANKS
·
Jan 22

Sight Sciences CEO Paul Badawi Reports Sale of Common Shares

Reuters
·
Jan 22

Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge Could Signal Some Risk

Simply Wall St.
·
Jan 21

Sight Sciences Falls on Expected FY Revenue Decline

Dow Jones
·
Jan 14

Sight Sciences Reports Preliminary Q4 Revenue

MT Newswires Live
·
Jan 14

Lake Street Reaffirms Their Buy Rating on Sight Sciences (SGHT)

TIPRANKS
·
Jan 13

BRIEF-Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights

Reuters
·
Jan 13

Sight Sciences Inc Q4 REV View $20.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 13

Press Release: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

Dow Jones
·
Jan 13

Sight Sciences Shares Rise After Piper Sandler Upgrade

MT Newswires Live
·
Jan 06

Sight Sciences Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive

Reuters
·
Jan 05

Piper Sandler Upgrades Sight Sciences to Overweight From Neutral, Adjusts Price Target to $9 From $5

MT Newswires Live
·
Jan 05

BUZZ-Piper Sandler upgrades Sight Sciences on strong business prospects

Reuters
·
Jan 05

Sight Sciences Is Maintained at Buy by UBS

Dow Jones
·
Dec 23, 2025

Director Staffan Encrantz Reports Acquisition of Sight Sciences Inc. Common Shares

Reuters
·
Dec 19, 2025

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
Dec 12, 2025